Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.
Artificial intelligence is no longer just spotting tumors a little faster than humans. In study after study, machine learning systems are uncovering hidden patterns in cancer data that even veteran ...
The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...
A new AI-powered tool is helping doctors find kidney cancer faster and more accurately. Researchers from the University of ...
Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated ...
Abbreviations: Carbo or cis, carboplatin or cisplatin; Cyclo, cyclophosphamide; Doxo, doxorubicin; ER, estrogen receptor; Her (per), pertuzumab; Her (TRAS ...
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
OncoInv, a Netherlands-based company focused on multi-cancer early detection, has signed a distribution agreement with MaxBloch Clinical Laboratories to introduce OncoSeek(R) , its multi-cancer early ...